semaglutide ruling US judge upholds FDA's removal of Ozempic, Wegovy from drug shortage list Hims is in the crosshairs.

However, these peripheral effects do not translate into increased food intake or body weight within 24 h following GLP-1 receptor blockade

Other GLP-1 receptor agonists may be considered, though they share a similar side effect profile

JOIN US PORTAL Accessibility Tools This website uses cookies so that we can provide you with the best user experience possible

This was the title of an editorial that accompanied the June paper in J AMA Ophthalmology described above: The editorial writer concluded: GLP-1 RAs have had a tremendous role in the care of patients with diabetes and now those needing additional help with weight management

Bibcode:2023PLoSO..1882898S